Chan WV, Pearson TA, Bennett GC, Cushman WC, Gaziano TA, Gorman PN, Handler J, Krumholz HM , Kushner RF, MacKenzie TD, Sacco RL, Smith SC, Stevens VJ, Wells BL
Among the GLP-1 medications included in this study, the authors found semaglutide showed a stronger association with reduced AFib risk than liraglutide, dulaglutide and tirzepatide.
The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity
Patients with uncontrolled hypothyroidism may experience worsening fatigue or other symptoms that could be confused with GLP-1 side effects
Antioxidant & Anti-Inflammatory Research GHK-Cu has demonstrated strong antioxidant properties in research, and studies have explored its ability to reduce inflammation and protect cells from oxidative damage mechanisms relevant to aging, tissue degeneration, and recovery research